A family history of infertility points you in the direction of testing, but it doesn't tell you which test to get. Most genetic causes of severe male infertility are sporadic. Klinefelter syndrome, the most common chromosomal cause, happens randomly during cell division. Y chromosome microdeletions often arise as new events because affected men historically couldn't pass them on. That means the panel matters more than the family tree.
The three tests in the standard panel
A reproductive urologist sees a short list of genetic tests regularly. Three of them do most of the diagnostic work.
Karyotype: the chromosome-level view
A karyotype looks at the number and structure of all 46 chromosomes in a blood sample. It catches the big problems: missing chromosomes, extra chromosomes, and large segments that have swapped places.
Klinefelter syndrome is the headline finding. Roughly 1 in 600 male births involves an extra X chromosome (47,XXY). Many men don't learn this until a fertility workup. The condition affects both sperm production and testosterone, so the result matters for hormone management too.
The test also catches balanced translocations. In a balanced translocation, two chromosomes have exchanged parts, but no genetic material is lost. The carrier is usually healthy. Sperm production can suffer because the rearrangement confuses the machinery that divides chromosomes during sperm formation. Balanced translocations also explain some cases of recurrent pregnancy loss, even when the semen analysis looks normal.
Y chromosome microdeletion testing
This is a targeted blood test. It searches for missing segments in three fertility regions of the Y chromosome, labeled AZFa, AZFb, and AZFc. The difference between those three regions matters enormously.
AZFc deletions are the most common finding. Studies across populations consistently report them in roughly 13 percent of men with azoospermia and about 5 to 6 percent of men with severe oligozoospermia, defined as concentrations below 5 million per milliliter. Men with an AZFc deletion often still have small pockets of sperm production. That matters for a man considering surgical sperm retrieval.
Complete AZFa and AZFb deletions are rarer but more decisive. Sperm retrieval in these men almost never succeeds. Knowing that before scheduling a microTESE attempt saves the man from surgery that won't work, and the conversation can shift to donor sperm or adoption.
CFTR gene testing
The CFTR gene is best known for cystic fibrosis, but certain mutations cause a specific male infertility pattern: congenital bilateral absence of the vas deferens, or CBAVD. Men with CBAVD produce sperm normally, but the tubes that carry it from the testes are missing from birth. They usually show up with azoospermia, low ejaculate volume, and normal hormone levels.
Most men with CBAVD carry at least one CFTR mutation. Testing confirms the diagnosis and triggers the next step: testing the female partner. If both parents carry a CFTR mutation, the child's risk for cystic fibrosis becomes a conversation that belongs before conception, not after.
When a doctor orders these tests
These tests are not routine for every man trying to conceive. They get triggered by specific findings.
The AUA and ASRM joint guideline on male infertility, published in 2021 in Fertility and Sterility, recommends karyotype and Y chromosome microdeletion testing for men with sperm concentrations below 5 million per milliliter. That threshold includes azoospermia and severe oligozoospermia.
CFTR testing sits in a narrower lane. It's recommended when the physical exam or semen analysis points to obstructive azoospermia: absent or impalpable vas deferens, low semen volume, or azoospermia with normal FSH and normal testicular volume.
Family history alone rarely triggers the full panel. A man with a normal semen analysis and a brother who struggled with infertility won't automatically get a karyotype. The exceptions: a documented CFTR mutation in the family, a known translocation in a relative, or a diagnosed genetic syndrome. The family history shapes how the doctor reads the result. The doctor uses the sperm count to decide whether the blood draw happens.
What the results actually change
A result doesn't treat anything. It changes which doors are open.
For Klinefelter syndrome, the conversation shifts to surgical sperm retrieval. Microsurgical testicular sperm extraction, or microTESE, finds sperm in roughly half of men with Klinefelter when performed at experienced centers. The retrieved sperm carries the man's own genetic material. The risk of passing the extra X chromosome to children is considered low but not zero, so genetic counseling is part of the discussion.
For AZFc deletions, sperm retrieval succeeds in the majority of men. The plan often moves to IVF with ICSI. For complete AZFa or AZFb deletions, the medical consensus is that retrieval won't work. Donor sperm or adoption becomes the realistic option. That's a hard conversation, but having it before surgery beats having it after.
For CFTR-related CBAVD, sperm retrieval is usually straightforward because production is intact. The bigger issue is the partner's carrier status and the risk to offspring. A genetic counselor belongs in that conversation.
Tests that get confused with genetic screening
Several tests get lumped in with genetic screening incorrectly. Knowing the difference saves confusion.
- Semen analysis is not a genetic test. It counts sperm and describes how they move and what they look like. It's the gatekeeper that determines whether the genetic panel makes sense at all.
- Sperm DNA fragmentation testing measures how much damage the DNA inside sperm has accumulated. It does not identify which genes are present or missing. It's a functional assessment, not a genetic diagnosis.
- The hormone panel (FSH, LH, testosterone, and prolactin) tells you whether the fertility problem is in the testes or in the brain. That's an endocrine question, not a genetic one.
- Expanded carrier screening is different from diagnostic genetic testing. It's a preconception screen offered to couples regardless of infertility, looking for recessive conditions including cystic fibrosis, spinal muscular atrophy, and others. It is broader than the male infertility panel but shallower in the specific information it returns for a man already diagnosed with azoospermia.
Research-level tests and what's coming
The standard panel identifies a genetic cause in roughly one in five men with azoospermia or severe oligozoospermia. The rest remains unexplained.
Research cohorts using whole exome sequencing have flagged candidate genes like TEX11 and DMRT1, but these are not yet routine clinical tests. Some commercial extended panels include a handful of these genes. The interpretation is still maturing, so a negative result from an extended panel doesn't rule out a genetic cause we haven't discovered yet.
If a man has unexplained azoospermia after the standard panel, an extended or research-based panel might find an answer. It might also find variants of uncertain significance, which create more questions than they answer. A genetic counselor can frame what to expect.
The practical sequence
The path starts with a semen analysis, not a genetic test. Family history is a signal, but the sperm count is the trigger.
If the count comes back below 5 million per milliliter, the karyotype and Y microdeletion tests follow. The blood draw is one visit. No surgery, no imaging. Results typically take a couple of weeks.
If the picture looks obstructive, CFTR testing gets added. If the standard panel is negative and the count is still severely low, a referral to a reproductive urologist is the next step, and the question of extended or research panels becomes concrete.
Family history is a nudge, not a diagnosis. The tests exist to turn that nudge into a plan you can actually work from.
This content is for educational purposes only and is not medical advice. Oakman products are designed for physical comfort and cooling; they make no claims about fertility, sperm quality, or hormone levels. Consult a healthcare professional for personalized advice.